1-8 of 8
Peter Matthiessen, PhD
Close
Save search
Sort by
Journal Articles

Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties

Free
Peter L. Turecek, PhD, Juergen Siekmann, PhD, Artur Mitterer, PhD, Michael Graninger, PhD, Gerald Schrenk, PhD, Peter Matthiessen, PhD, Hanspeter Rottensteiner, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2015) 126 (23): 3536.
https://doi.org/10.1182/blood.V126.23.3536.3536
Published: 2015
Journal Articles

Temperature-Dependent Irreversible Conformational Change of ADAMTS13 upon Metal Ion Chelation

Free
Rana Grillberger, PhD, Stefan Kaufmann, Barbara Kink, Peter Matthiessen, PhD, Barbara Plaimauer, PhD, Friedrich Scheiflinger, PhD, Hanspeter Rottensteiner, PhD
Journal: Blood
Blood (2015) 126 (23): 2238.
https://doi.org/10.1182/blood.V126.23.2238.2238
Published: 2015
Journal Articles

Structural Characterization of Baxter's Recombinant Human ADAMTS13 Drug Candidate.

Free
Alexandra Foettinger-Vacha, Martin Kaliwoda, PhD, Peter Matthiessen, PhD, Meinhard Hasslacher, PhD, Hanspeter Rottensteiner, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 2236.
https://doi.org/10.1182/blood.V120.21.2236.2236
Published: 2012
Journal Articles

Structural Characterization of BAX 855, a PEGylated Recombinant FVIII

Free
Martin Kaliwoda, PhD, Michael Graninger, PhD, Peter Matthiessen, PhD, Gerald Schrenk, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2011) 118 (21): 4356.
https://doi.org/10.1182/blood.V118.21.4356.4356
Published: 2011
Journal Articles

Modification of rVWF with Polysialic Acid: Biochemical and Functional Characterization in Mice with VWD.

Free
Peter L. Turecek, PhD, Juergen Siekmann, PhD, Alfred Weber, PhD, Herbert Gritsch, PhD, Katalin Váradi, PhD, H. Peter Matthiessen, PhD, Eva-Maria Muchitsch, DVM, Bernhard Baumgartner, DVM, Hans Peter Schwarz, MD
Journal: Blood
Blood (2006) 108 (11): 1001.
https://doi.org/10.1182/blood.V108.11.1001.1001
Published: 2006
Journal Articles

PEG Modified rVWF Prolongs the Survival of Native rFVIII in Hemophilia A Knock-Out Mice.

Free
Peter L. Turecek, PhD, Friedrich Scheiflinger, PhD, Herbert Gritsch, PhD, Bernhard Baumgartner, DVM, Katalin Váradi, PhD, H. Peter Matthiessen, PhD, Juergen Siekmann, PhD, Eva-Maria Muchitsch, DVM, Hans Peter Schwarz, MD
Journal: Blood
Blood (2006) 108 (11): 1002.
https://doi.org/10.1182/blood.V108.11.1002.1002
Published: 2006
Journal Articles

Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.

Free
Peter L. Turecek, PhD, H. Peter Matthiessen, PhD, Artur Mitterer, PhD, Herbert Gritsch, PhD, Katalin Váradi, PhD, Barbara Plaimauer, PhD, Martin Purtscher, PhD, Wilfried Woehrer, PhD, Eva-Maria Muchitsch, DVM, Hans Peter Schwarz, MD
Journal: Blood
Blood (2006) 108 (11): 1017.
https://doi.org/10.1182/blood.V108.11.1017.1017
Published: 2006
Journal Articles

Biochemical and Functional Characterization of PEGylated rVWF.

Free
Peter L. Turecek, PhD, Friedrich Scheiflinger, PhD, Juergen Siekmann, PhD, Katalin Váradi, PhD, H. Peter Matthiessen, PhD, Alfred Weber, PhD, Herbert Gritsch, PhD, Eva-Maria Muchitsch, DVM, Bernhard Baumgartner, DVM, Hans Peter Schwarz, MD
Journal: Blood
Blood (2006) 108 (11): 1021.
https://doi.org/10.1182/blood.V108.11.1021.1021
Published: 2006